EVEREST-HN 1: EVolution of a patiEnt-REported Symptom-based Risk Stratification sySTem

EVolution of a patiEnt-REported Symptom-based Risk Stratification sySTem to Redesign the Suspected Head and Neck Cancer Referral Pathway (Phase 1)

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05909020

Enrollment

165

Registered

2023-06-18

Start date

2023-03-17

Completion date

2023-11-30

Last updated

2023-10-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Head and Neck Cancer

Brief summary

Can a patient-reported symptom-based risk stratification system improve the suspected head and neck cancer (HNC) pathway? Our methodology includes six interlinked work packages to deliver our aim, with EVEREST-HN 1 encompassing the first of these and seeking to optimise a patient-reported symptom inventory for HNC and outline requirement specification for the SYmptom iNput Clinical (SYNC) system.

Detailed description

The EVEREST-HN pathway should be based on a comprehensive understanding of existing HNC diagnostic pathways and what patients and clinicians value in these. The language used within the EVEREST pathway needs to be accessible and optimal to elicit appropriate information.

Interventions

OTHERNo intervention.

No intervention.

Study design

Observational model

OTHER

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

Patients: * Adults ≥ 18 years referred via suspected HNC pathway without previous history of HNC * Participants willing and able to give informed consent for participation in the study. Clinicians: * Staff at participating sites involved in the diagnostic pathway for people with suspected HNC.

Exclusion criteria

* Individuals who do not meet the inclusion criteria.

Design outcomes

Primary

Measure	Time frame	Description
Inventory and specification for the SYmptom iNput Clinical (SYNC) system	September 2022 - August 2023	To optimise a patient-reported symptom inventory for HNC and outline requirement specification for the SYmptom iNput Clinical (SYNC) system

Secondary

Measure	Time frame	Description
To further explore the current suspected HNC pathway and the language used when discussing symptoms.	September 2022 - August 2023	To understand how clinicians decide subsequent steps for patients referred with suspected HNC, the language patients and clinicians use to describe symptoms and patients' and clinicians' views and experiences of the current diagnostic process for HNC. with a focus on what would work for EVEREST-HN study.

Countries

United Kingdom

Contacts

Primary ContactSarah Webb

EVEREST-HN@rmh.nhs.uk0208 915 6666

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026